Correction: Antimicrobial, anticancer activities and molecular docking of eco-friendly chitosan nanocapsule loaded with biosynthesized titanium nanoparticles by Aspergillus flavus)
Frontiers in Microbiology · 29.10.2026 · 17
DOI: 10.3389/fmicb.2026.1980880 ↗Kurz gefasst
Korrektur in der Zeitschrift Frontiers in Microbiology, online erschienen am 29.10.2026. Verfasst von Nashwa El-Gazzar und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, Egypt. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
[This corrects the article DOI: 10.3389/fmicb.2026.1741753.].
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Botany and Microbiology, Faculty of Science, Zagazig University, Zagazig, Egypt.
- Department of Clinical Microbiology, Infection and Immunology, Umeå University, Umeå, Sweden.
- Department of Diagnostics and Intervention, Oncology, Umeå University, Umeå, Sweden.
Zitieren
APA
El-Gazzar, N., Rafat, M., Rabie, G., & Sitohy, B. (2026). Correction: Antimicrobial, anticancer activities and molecular docking of eco-friendly chitosan nanocapsule loaded with biosynthesized titanium nanoparticles by Aspergillus flavus). Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1980880
Vancouver
El-Gazzar N, Rafat M, Rabie G, Sitohy B. Correction: Antimicrobial, anticancer activities and molecular docking of eco-friendly chitosan nanocapsule loaded with biosynthesized titanium nanoparticles by Aspergillus flavus). Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1980880
BibTeX
@article{ElGazzar2026,
author = {El-Gazzar, Nashwa and Rafat, Marwa and Rabie, Gamal and Sitohy, Basel},
title = {Correction: Antimicrobial, anticancer activities and molecular docking of eco-friendly chitosan nanocapsule loaded with biosynthesized titanium nanoparticles by Aspergillus flavus)},
journal = {Frontiers in Microbiology},
year = {2026},
volume = {17},
doi = {10.3389/fmicb.2026.1980880}
}
EUVIMED